| Sai Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544306 |
NSE Symbol : SAILIFE |
P/E(TTM) : 68.86 |
|
ISIN Demat : INE570L01029 |
Div & Yield% : 0.00 |
EPS(TTM) : 15.82 |
|
Book Value(₹) : 108.77 |
Market Cap(₹Cr) : 23,069.11 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 594.34 | 549.18 | 526.67 | 483.04 | 567.01 | 428.60 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 594.34 | 549.18 | 526.67 | 483.04 | 567.01 | 428.60 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 16.04 | 8.45 | 14.93 | 10.01 | 9.82 | 9.45 |
| Total Income | 610.38 | 557.63 | 541.60 | 493.04 | 576.83 | 438.05 |
| Total Expenditure | 426.20 | 378.50 | 386.82 | 370.04 | 413.11 | 317.41 |
| PBIDT | 184.18 | 179.13 | 154.78 | 123.00 | 163.72 | 120.64 |
| Interest | 6.16 | 8.06 | 7.70 | 10.70 | 9.16 | 21.66 |
| PBDT | 178.02 | 171.07 | 147.08 | 112.31 | 154.56 | 98.98 |
| Depreciation | 41.16 | 40.60 | 36.21 | 34.33 | 34.10 | 31.07 |
| Tax | 14.03 | 30.79 | 29.28 | 13.86 | 17.53 | 9.90 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 20.29 | 2.05 | -1.36 | 5.76 | 13.00 | 6.95 |
| Reported Profit After Tax | 102.53 | 97.63 | 82.95 | 58.37 | 89.94 | 51.06 |
| Extra-ordinary Items | 0.22 | -6.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 102.31 | 103.84 | 82.95 | 58.37 | 89.94 | 51.06 |
| EPS (Unit Curr.) | 4.85 | 4.64 | 3.97 | 2.80 | 4.32 | 2.74 |
| EPS (Adj) (Unit Curr.) | 4.85 | 4.64 | 3.97 | 2.80 | 4.32 | 2.74 |
| Calculated EPS (Unit Curr.) | 4.84 | 4.62 | 3.95 | 2.80 | 4.32 | 2.45 |
| Calculated EPS (Adj) (Unit Curr.) | 4.84 | 4.62 | 3.95 | 2.80 | 4.32 | 2.45 |
| Calculated EPS (Ann.) (Unit Curr.) | 19.37 | 18.49 | 15.81 | 11.20 | 17.26 | 9.82 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 19.37 | 18.49 | 15.81 | 11.20 | 17.26 | 9.82 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 21.18 | 21.12 | 20.98 | 20.86 | 20.84 | 20.80 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 30.99 | 32.62 | 29.39 | 25.46 | 28.87 | 28.15 |
| PBDTM(%) | 29.95 | 31.15 | 27.93 | 23.25 | 27.26 | 23.09 |
| PATM(%) | 17.25 | 17.78 | 15.75 | 12.08 | 15.86 | 11.91 |
